Ekaterina Vadimovna Orlova

Ekaterina Vadimovna Orlova

Auto-generated profile, based on publicly available information

Ekaterina Vadimovna Orlova

Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
VSVladislav Sergeevich Skossyrskiy
Vladislav Sergeevich Skossyrskiy
MBMaxim Boot
Maxim Boot
IGIgor Gadaev
Igor Gadaev
Marina I. SekachevaMarina I. Sekacheva
Marina I. Sekacheva
EOEkaterina Orlova
Ekaterina Orlova

19 May 2022
Verified
Conference Paper
Closed access
PDF file
AGAnastasia Guryleva
Anastasia Guryleva
AMAlexander S. Machikhin
Alexander S. Machikhin
DKDemid Khokhlov
Demid Khokhlov
MVMikhail Volkov
Mikhail Volkov
VBValeriya I. Bukova
Valeriya I. Bukova
LSLyudmila M. Smirnova
Lyudmila M. Smirnova
Identification of specific vascular patterns in skin formations is important for non-invasive differential diagnosis of benign and malignant tissues. Accurate blood vessel mapping and quantitative analysis of the vessels morphology may increase the diagnostic efficiency significantly in comparison to conventional dermatoscopy methods. In this paper, we propose videocapillaroscopy technique for non-invasive visualization of microvascular architecture right in the nevi area. It includes acquisition of skin lesion images by exoscope-based imaging system and their digital processing including non-uniformity correction, local and global stabilization, detection and quantification of vessels, comparison of the obtained vessel maps with the reference data. We have demonstrated the efficiency of microvascular network visualization in various melanocytic skin formations. Proposed technique may complement conventional dermatoscopy for diagnosing skin lesions and become especially effective in the early stages of diseases.

25 June 2020 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
YZYaqun Zhang
Yaqun Zhang
SQShengnu Qiu
Shengnu Qiu
EOEkaterina Orlova
Ekaterina Orlova

25 October 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
VSVladislav Sergeevich Skossyrskiy
Vladislav Sergeevich Skossyrskiy
NKNatalya A. Kurdina
Natalya A. Kurdina
VKViktoriya S. Kuzovkova
Viktoriya S. Kuzovkova
MBMaxim S. Boot
Maxim S. Boot
PZPolina I. Zelenchenkova
Polina I. Zelenchenkova
EOEkaterina V. Orlova
Ekaterina V. Orlova

15 August 2019 in Russian Journal of Skin and Venereal Diseases
Verified
Journal Article
Open access
PDF file
EOEkaterina V. Orlova
Ekaterina V. Orlova
AZA. S Zybareva
A. S Zybareva
LSL. M Smirnova
L. M Smirnova
LKL. N Kayumova
L. N Kayumova
DMD. M Martynenko
D. M Martynenko
КНКаюмова Л. Н
Каюмова Л. Н
The skin ecosystem (microbiome) is a complex environment represented by a diverse community of microorganisms with various mechanisms of interaction with each other and the epidermis. The structure of colonization varies depending on the localization on the skin and environmental changes. There is a complex mechanism of the indirect influence of microorganisms through Toll-like receptors (TLR2) in the skin on the activation of the cascade of reactions leading to the production of antimicrobial peptides. This is the basis for the development of chronic inflammation, provoking mechanisms of carcinogenesis in skin cells. The mechanisms of influence of the commensal flora on the skin condition, the change in its regenerative capabilities have been little studied. Modern ideas about the importance of skin microbiota in the mechanisms of development of frequently occurring dermatoses are presented.

3 September 2021 in Russian Journal of Skin and Venereal Diseases
Verified
Journal Article
Closed access
PDF file
EOEkaterina V. Orlova
Ekaterina V. Orlova
ОВОрлова Екатерина Вадимовна
Орлова Екатерина Вадимовна
The binding of epidermal growth factor (EGFR) receptors is a good target for the treatment of lung, colon, pancreatic, head and neck cancers. The adverse events that develop as a result of therapy, in the form of lesions of the skin and mucous membranes, is a serious problem for the doctor to choose a long-term treatment strategy. The developing symptoms of skin toxicity, as skin problems in patients are often called, are worrisome and often affect the quality of life and compliance with the treatment regimen. Thus, it is important for doctors to know the prerequisites and ways to manage skin toxicity associated with the use of tyrosine kinase receptor inhibitors of epidermal growth factor. The mechanism and consequences of EGF receptor activation are described to explain the development of undesirable skin toxicity associated with inhibition of the epidermal growth factor receptor.